In order to clarify the severity of SIRS, one can use the assessment of the level of specific markers in blood plasma, such as interleukin 1 (IL-1), interleukin 6 (IL-6), interleukin 10 (IL-10) and tumor necrosis factor alpha (TNF-α). This evidence concerns the gene IL6 and systemic inflammatory response syndrome.